Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with BRAF V600-mutated Metastatic Melanoma
published in: Clinical Cancer Research
date of publication: 2019-03-01
main subject: metastatic melanoma
Cites articles
There is nothing here
Article - wd:Q92060564